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Abstract
Impaired social function is a core feature of many psychiatric illnesses. Adverse experiences during childhood increase
risk for mental illness, however it is currently unclear whether stress early in life plays a direct role in the development
of social difﬁculties. Using a rat model of pre-pubertal stress (PPS), we investigated effects on social behaviour, oxytocin
and arginine vasopressin (AVP) in the periphery (plasma) and centrally in the paraventricular and supraoptic
hypothalamic nuclei. We also explored social performance and AVP expression (plasma) in participants with borderline
personality disorder (BPD) who experienced a high incidence of childhood stress. Social behaviour was impaired and
AVP expression increased in animals experiencing PPS and participants with BPD. Behavioural deﬁcits in animals were
rescued through administration of the AVPR1a antagonist Relcovaptan (SR49059). AVP levels and recognition of
negative emotions were signiﬁcantly correlated in BPD participants only. In conclusion, early life stress plays a role in
the precipitation of social dysfunction, and AVP mediates at least part of this effect.
Introduction
Altered social function is a core component of several
adult psychiatric illnesses. For example, depression and
schizophrenia are commonly associated with social
withdrawal, while major personality disorders can be
associated with unstable social relationships (borderline
personality disorder, BPD) or aggressive interactions
(antisocial personality disorder)1–4. Impairments in social
behaviour can also be a key determinant of functional
outcome in these conditions5–7. However, relatively little
is known about the causes of impaired social function in
psychiatric conditions and their relationship to important
aetiological factors associated with psychiatric disorders
such as developmental stressors.
Early life stress has been shown to impact on social
behaviour and functioning in both animal and human
studies8–13. In rodent models, social stressors such as
social isolation and social defeat during development
negatively impact social function in adulthood, and
interestingly non-social, physical stressors are also capable
of eliciting substantial changes in social function12,14,15.
The exact nature and timing of stress often inﬂuences
later outcomes. The majority of studies have focussed on
stressors early in development such as maternal separa-
tion, but less is known about the effects of stress in the
post-weaning, pre-pubertal phase, a time-point suggested
as more akin to human childhood16–18. During the pre-
pubertal and adolescent phases the limbic system and
prefrontal cortex are undergoing signiﬁcant maturation.
These areas are intimately involved in social function and
extremely stress reactive due to high densities of corti-
costeroid receptors19. Therefore, stress during this time is
predicted to have signiﬁcant negative impacts on social
function. Studies to date have revealed that non-social
stress during the peri-pubertal phase results in enhanced
aggression, and physical, pre-pubertal stressors alter social
interaction in adulthood12,15,20–25. In humans, adverse
early life experiences have been strongly associated with a
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range of later difﬁculties in social interaction in long-
itudinal and cross-sectional studies8,9,26,27. In particular,
childhood and adolescent stressors have been linked to
later social anxiety, withdrawal and aggression, although
there is substantial variation in outcomes and not all
exposed individuals are affected28–32. There is also sub-
stantive evidence that childhood adversity is associated
with an increased risk for psychiatric disorders in which
altered social interaction is a prominent feature, including
social anxiety, depression and personality disorders33–35.
A particularly strong association between developmental
adversity and later illness is seen in the case of BPD in
which impaired social interactions are a core feature of
the presentation34,36–40. BPD is also characterised by an
unstable sense of self, interpersonal sensitivity, impulsiv-
ity, cognitive disturbances (e.g., verbal comprehension,
visual attention, working memory and processing speed)
and intense, volatile emotions41–43. There is currently a
lack of valid animal models that translate the key features
of BPD, but the role of early life stress has recently been
highlighted as a contributing aetiological factor that is
amenable to study in animal models44. Indeed, certain
features of BPD are paralleled by behavioural disturbances
following peri-pubertal stress in animal models. For
example, rodents exposed to physical or social stress
during this period exhibit altered impulsivity and com-
pulsivity and impaired working memory45–47.
The mechanisms through which early life stressors
impact later social behaviour are still largely unknown.
The evolutionarily conserved social neuropeptides oxy-
tocin (OXT) and arginine vasopressin (AVP) are known to
play an important role in social behaviour across spe-
cies48–52. AVP and OXT are evolutionarily ancient non-
apeptides found in various guises throughout the animal
kingdom53. In mammals, they are predominantly manu-
factured in the paraventricular and supraoptic nuclei of
the hypothalamus, and released into peripheral circulation
via the pituitary gland48. OXT and AVP play a wide
variety of roles in social behaviour in animals, ranging
from inter-male and maternal aggression, conspeciﬁc
afﬁliation, social cognition and sexual behaviour48,50,51. In
humans, intranasal administration of both OXT and AVP
inﬂuence emotion processing and social cognition, and
genetic and functional neuroimaging studies demonstrate
a role for OXT and AVP on social behaviour and related
limbic brain circuitry54,55.
Maternal separation in rodents has been shown to
increase AVP levels speciﬁcally in the paraventricular
nucleus (PVN) and alter OXT levels and OXT/AVP
receptor binding in an age and sex speciﬁc manner in the
offspring17,56–58. However, less is known about the effects
of stressors applied pre-pubertally, a period which may be
more analogous to human childhood, on social peptide
regulation. In humans, experience of childhood
maltreatment has been associated with decreased levels of
OXT in women and men, but the effects of early life stress
on AVP levels are less well known59.
Here, we report three experiments investigating the
relationship between early life stress, AVP/OXT and
social behaviour. The aim of experiment 1 was to inves-
tigate the effects of pre-pubertal stress (PPS) on social
behaviour and levels of OXT and AVP in adult animals.
Experiment 2 sought to determine whether changes in
social behaviour resulting from PPS could be reversed
thorough AVP receptor antagonism, using the AVPR1a
antagonist Relcovaptan (SR49059). The third and ﬁnal
experiment assessed peripheral levels of AVP in patients
with BPD (a group with a high incidence of childhood
adversity) and controls and related these to social
behaviour.
Materials and methods
Experiments 1 and 2
Subjects
Female and male Lister Hooded rats were bred in house
from adult pairs (Charles River) at Cardiff University.
Litters were weaned on postnatal day (PND) 21 and
housed in same sex cages (32 × 50 × 21 cm) with litter-
mates. Cages were lined with wood shavings, a cardboard
tube and wooden stick were provided as enrichment, light
was maintained on a 12:12-h light/dark cycle and food
and water were provided ad libitum. All animal experi-
mental methods were carried out in accordance with
relevant guidelines and regulations of the European reg-
ulations on animal experimentation (Directive 2010/63/
EU) and the UK Home Ofﬁce Animals (Scientiﬁc Proce-
dures) Act 1986. All experimental protocols were
approved by the local ethical review body (AWERB) of
Cardiff University. Eighty rats (male: 20 control, 20 PPS;
female: 20 control, 20 PPS) were used for social testing in
experiment 1, and one hundred and forty four (female: 22
control and vehicle, 24 control and Relcovaptan, 20 PPS
and vehicle, 30 PPS and Relcovaptan; male: 12 control
and vehicle, 14 control and Relcovaptan, 10 PPS and
vehicle, 12 PPS and Relcovaptan) in experiment 2. In a
separate cohort of animals (not subjected to behavioural
testing), forty rats (male: 12 control, 10 PPS; female: 8
control, 10 PPS) were used for plasma collection (per-
ipheral AVP), and a further 44 rats (male: 10 control, 13
PPS; female: 10 control, 11 PPS) for immunohistochem-
istry (central AVP).
Pre-pubertal stress
PPS was given to half of the litters on PND 25–27. This
protocol has been described previously60–62, and was
originally described by Jacobson-Pick and Richter-Levin63.
Brieﬂy, animals were given a 10min swim stress in an
opaque swimming tank (25 cm high, 34 cm diameter),
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12 L capacity ﬁlled with 6 L of 25 ± 1 °C water on PND 25,
3 sessions of 30 min restraint stress (separated by 30 min
breaks in the home cage) in plastic restraint tubes (15 cm
length, 5 cm diameter) on PND 26, and three 30 min
elevated platform exposures (separated by 60min breaks
in the home cage) on elevated platforms (15 × 15 cm,
115 cm high) on PND 27. Stressors took place in a
designated room, separate from the holding room. After
PPS, animals were returned to their home cages and
holding rooms and left undisturbed (aside from cage
cleaning) until early adulthood (PND 60–67). Litters were
randomly allocated to experimental groups (PPS or con-
trol) based on order of birth. A minimum of ﬁve litters per
group were used to minimise the effects of pseudo-
replication, and litter of origin was accounted for in all
statistical analyses.
AVPR1a antagonist
Relcovaptan (AVPR1a antagonist SR49059, Axon
Medchem BV, The Netherlands) was dissolved in 15%
dimethyl sulfoxide (DMSO) and 2% Tween 80 in 0.9%
saline and administered intraperitoneally at a volume of
2 ml/kg. The dose selected was 1 mg/kg, as this dose
reliably inhibits prosocial and autonomic effects of per-
ipherally administered AVP64,65. Vehicle was 15% DMSO
and 2% Tween 80 in 0.9% saline.
Social testing
Testing took place in a clear acrylic tank (65 cm ×
65 cm × 40 cm high) placed on the ﬂoor in the centre of a
dimly lit room (30 lux). Interactions were ﬁlmed from
above, and a microphone was suspended above the tank,
connected to Avisoft SASLab Pro (avisoft bioacoustics,
Germany) to capture ultrasonic vocalisations, which are
frequently emitted during murine social encounters.
Videos were then watched back by an observer blind to
group, and a range of common social behaviours were
analysed, as well as latency to initial contact, duration of
each contact, number of contacts and total contact time.
Speciﬁc behaviours recorded were divided into two cate-
gories, ‘aggressive’ consisting of boxing, biting, ﬁghting,
mounting, pinning (one rat rolls onto back, and other pins
from above), nose off (rats stand immobile facing one
another with all four paws on the ground, a defensive
strategy), run away, crawl over (one rat crawls over
another, often marking with urine), head under body of
the other animal, and ‘benign or friendly’ consisting of
allogrooming, snifﬁng and following. Recorded vocalisa-
tions were analysed with Avisoft SASLab Pro programme.
Very few 22 kHz vocalisations were produced, so all
analyses are based on 50 kHz vocalisations. In rats, 22 kHz
vocalisations are most often emitted in aversive situations
(e.g., presence of predators, pain), whereas 50 kHz reﬂect
more positive affective states (e.g., during social contact,
mating, in response to drugs of abuse or food)66.
Three hours before testing, animals were single housed
in their holding room, to increase the desire for social
contact. One hour before testing they were transferred to
the testing room, to habituate them to this environment.
In experiment 2 only, half of the animals from each group
were given 1 mg/kg Relcovaptan via intraperitoneal
injection 30min before testing, the remaining half were
administered vehicle only. During testing, two stranger
animals were placed into opposite sides of the arena,
facing the wall, and allowed to freely interact for 15min.
After this time they were returned to their home cages.
The arena was cleaned with ethanol wipes between pairs
of animals. Animals were tested in same-sex pairs, with
each member of a given pair originating from the same
group and treatment condition (PPS or control, vehicle or
Relcovaptan) but different litters, so the animals had not
previously met. Each pair was treated as one experimental
unit for behavioural analysis.
Tissue and plasma collection
Experiment 1 For plasma AVP and OXT analyses,
animals were sacriﬁced at PND 60 using a rising
concentration of CO2, decapitated and trunk blood was
collected using EDTA microvette collection tubes (Sar-
stedt, Germany). Blood was spun at 1500 × g for 10 min,
plasma was removed and stored at −20 °C. For immuno-
histochemistry, animals were killed at PND 60 by
transcardial perfusion with 0.01M phosphate-buffered
saline and 4% paraformadelhyde (PFA) under anaesthesia
for immunohistochemical analysis of AVP in the
supraoptic and paraventricular nuclei. Brains were left
in PFA overnight (4 °C), then transferred to 30% sucrose
solution for cryoprotection. Coronal 30 µm sections were
cut through the entire hypothalamic extent on a freezing
microtome (Leica RM2245) and placed into a solution of
cryoprotectant for storage at −20 °C until immunohisto-
chemical analysis.
Experiment 2 After social testing animals were culled
(half of the animals were culled 20min after testing
(direct), the rest 1 week later (delayed)) and trunk blood
samples taken as in experiment 1.
ELISA assays
For experiment 1, rat plasma samples were assayed
untreated. For experiment 2 and all human samples,
plasma samples were dried down by adding 2:1 ice-cold
acetone:plasma, centrifuging at 3000 × g for 20 min,
transferring the supernatant, adding 5× supernatant
volume of ice-cold petroleum ether to the supernatant,
centrifuging at 3000 × g for 10 min, discarding the top
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ether layer and drying the remaining aqueous layer under
nitrogen gas. This remaining pellet was reconstituted
with 250 µl of assay buffer and used for ELISA analysis.
Arg8-vasopressin and OXT (Enzo Life Sciences, UK)
ELISAs were conducted according to the manufacturer’s
instructions.
Immunohistochemistry
Three sections per animal per region (supraoptic
nucleus (SON) and PVN) were stained for AVP. These
were matched for bregma between different animals.
Sections were washed between each step for 3 × 5min in
0.01M Tris-buffered saline (TBS, pH 7.4) and all steps
were carried out at room temperature unless otherwise
speciﬁed. Sections were blocked with BLOXALL (Vector
laboratories, UK) for 10min, then blocking solution (2%
goat serum, 0.3% Triton-X in 0.01M TBS) for 60min,
rabbit anti-AVP (1:7500 in blocking solution, AB1565,
Millipore, UK) for 24 h followed by biotinylated goat-anti-
rabbit (3 µg/ml in blocking solution) for 45min, then
30min in VECTASTAIN ABC reagent (avidin-biotiny-
lated horseradish peroxidase complex, Vector Labora-
tories, UK), before developing in diaminobenzidine
solution (Vector Laboratories, UK) for 5 min. Washed
sections were mounted onto glass microscope slides and
coverslipped with Vectamount (Vector Laboratories, UK).
Slides were then imaged at 20× using an Axio Scan Z1
(Zeiss). The optical density of AVP immunoreactive cells
in the supraoptic and paraventricular nuclei were quan-
tiﬁed as grey density per area minus background in digi-
tised images using Zen Blue software (Zeiss).
Data analysis
Data were analysed using generalised linear models in
JMP (statistical software, SAS Institute, Cary, NC, USA).
Group (control or PPS), sex, Relcovaptan/vehicle
(experiment 2 only), direct or delayed sacriﬁce (experi-
ment 2 only) and all interactions were ﬁtted as factors,
and latency to contact, total contact time, average contact
duration, speciﬁc behaviour (boxing, biting, ﬁghting,
mounting, pinning, nose offs, run away, crawl over, allo-
grooming and following), number and duration of voca-
lisations, AVP and OXT were ﬁtted as responses.
Spearman’s Rho was used to assess correlations between
behavioural and AVP measures. Unlike AVP measures, it
was not possible to obtain individual social data for each
animal, as animals were tested in pairs, so the behavioural
data for the pair was used in correlational analyses. P was
adjusted to 0.004 to account for multiple comparisons.
Experiment 3
Participants
A total of 20 people with BPD were recruited from the
National Centre for Mental Health (NCMH, Welsh
Government funded research centre) participant pool
database. Patients with BPD were chosen as this condition
is typically associated with very high levels of childhood
trauma67. A total of 18 healthy age and sex matched
controls with no psychiatric disorder were recruited from
the community. Exclusion criteria for all participants
included current substance dependence, neurological ill-
ness, psychotic disorder diagnosis (bipolar I or schizo-
phrenia) and pregnancy, and additionally no psychiatric
disorder for control participants. The BPD group con-
sisted of 16 females and 4 males, mean age 43.4 (range:
25–71), controls 14 females and 4 males, mean age 38.4
(range: 20–64). In the BPD group, 11 were being treated
with antipsychotic medication and 13 were being treated
with antidepressant medication. BPD diagnosis was con-
ﬁrmed in the BPD group and excluded in the controls
using the SCID-II (Structured Clinical Interview for DSM
Disorders II). Current symptoms of depression were rated
using the Hamilton Rating Scale for Depression (HADS).
Participants also completed the Childhood Trauma
Questionnaire (CTQ), a self-report measure of incidence
and severity of childhood trauma consisting of 28 state-
ments relating to one of ﬁve subscales of neglect (physical
and emotional) or abuse (emotional, physical and sexual).
The study was approved by the NHS research ethics
committee, and all participants gave informed, written
consent, had the opportunity to discuss the study and
understood they were free to withdraw at any point.
Social testing
Participants were given the Ekman 60 faces task, which
assess overall emotion recognition performance and
identiﬁcation of basic emotions. During testing, 60 dif-
ferent faces were presented one by one on a computer
screen for 3 s, depicting the faces of actors portraying one
of six basic emotions (fear, disgust, anger, sadness, hap-
piness and surprise). Ten incidents of each emotion were
portrayed during the task. Participants were given as long
as needed to identify the emotion. The response choices
were shown on the screen, and participants made their
selection using a computer mouse. Responses were
recorded automatically. Faces were selected from the
Ekman and Friesen series of Pictures of Facial Affect68, a
widely used and validated series of photographs in facial
expression research.
Sample collection and analysis
Participants were visited in their own homes. Blood
samples were collected from participants before ques-
tionnaire administration and social testing. In total, blood
samples were obtained from 17 BPD and 15 controls.
Samples were placed in cool bags containing reusable
freezer blocks and transferred to the laboratory where
they were centrifuged at 16,000 × g for 15 min at 4 °C. The
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cell-free supernatant plasma fraction was removed and
transferred to −80 °C storage until analysis. AVP was
analysed in plasma following the same protocol as for
animal samples, using human Arg8-vasopressin ELISA kit
(Enzo Life Sciences, UK). Copeptin was analysed using
human copeptin ELISA (Novus Biologicals, UK), accord-
ing to manufacturer’s instructions.
Data analysis
Data were analysed using generalised linear models or
Mann–Whitney U tests in JMP (statistical software, SAS
Institute, Cary, NC, USA). Data were checked for nor-
mality and homogeneity of variance and transformed to ﬁt
these assumptions when necessary. If data could not be
transformed, non-parametric tests were used. For AVP
and copeptin, group was ﬁtted as a factor with AVP/
copeptin as a response. For the Ekman task, group (con-
trol or BPD), emotion (fear, disgust, anger, sadness, hap-
piness and surprise) and group*emotion were ﬁtted as
factors, and number of correct responses as the response.
Subject was nested within group and ﬁtted as a random
factor to account for repeated measures. Due to non-
normal, non-homogenous data, Mann–Whitney U tests
were used to analyse responses to the HADS and CTQ
questionnaires. Spearman’s Rho was used to assess cor-
relations between (i) EKMAN and AVP measures, (ii)
CTQ and AVP measures and (iii) CTQ and EKMAN
measures. P values were adjusted using the Bonferroni
correction to account for multiple comparisons.
Results
Experiment 1
In experiment 1 we investigated the effects of PPS on
social behaviour and AVP expression in adult rats. PPS
decreased latency to initial social contact (F1,35= 4.27,
p= 0.046), decreased duration of each individual con-
tact bout (F1,35= 7.68, p= 0.009) and decreased number
(F1,36= 10.17, p= 0.003) and duration (F1,36= 7.78, p=
0.008) of positively valanced ultrasonic vocalisations
(50 kHz), and shortened maximum duration of vocali-
sations (F1,36= 4.13, p= 0.049) in males and females
(Fig. 1a–d). No biting or ﬁghting were observed, and
only nose-offs, snifﬁng, crawl overs and follows occur-
red frequently, with other behaviours rarely observed.
There was no effect of PPS on the total number of
contacts made (F1,35= 2.25, p= 0.14), total contact time
(F1,35= 1.27, p= 0.27) or time engaged in any speciﬁc
behaviour (boxing, nose-offs, mounts, pinning, run away
crawl over, head under body, allogrooming or following,
see Supplementary Table 1 for full statistical results).
There were also sex differences in social behaviour, with
males displaying increased duration of individual con-
tact bouts (F1,35= 7.35, p= 0.01), greater total contact
time (F1,35= 5.31, p= 0.03), fewer incidents of running
away (F1,35= 5.53, p= 0.02) and more crawl overs (F1,35=
5.23, p= 0.03), and females generating more ultrasonic
vocalisations (F1,36= 5.73, p= 0.02) for a longer duration
(F1,35= 4.73, p= 0.04) and greater maximum duration
(F1,35= 10.99, p= 0.02).
Fig. 1 Social behaviour after PPS. PPS animals were a faster to initiate contact, b displayed shorter duration of contacts, c emitted fewer
vocalisations which were d of shorter duration. *p < 0.05, **p < 0.01. Con control, PPS pre-pubertal stress. Error bars represent 1 S.E.
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In separate cohorts (not behaviourally tested) PPS
resulted in higher AVP levels in plasma (F1,36= 4.29, p=
0.04, Fig. 2a) and centrally in the supraoptic (F1,39= 5.31,
p= 0.03, Fig. 2b) but not paraventricular (F1,36= 0.23,
P= 0.64, Fig. 2c, d) nucleus of the hypothalamus as
assessed by immunohistochemistry. PPS did not inﬂuence
plasma levels of OXT (F1,36= 0.01, p= 0.91). There were
no effects of sex on plasma AVP (F1,36= 1.42, p= 0.24) or
AVP in the supraoptic (F1,36= 1.33, p= 0.26) or para-
ventricular (F1,36= 0.09, p= 0.76) nucleus.
Experiment 2
In experiment 2, we investigated the ability of an AVPR1a
antagonist, Relcovaptan, to rescue behavioural changes
induced through PPS in our animal model. As in experiment
1, PPS signiﬁcantly increased plasma levels of AVP in these
animals (F1,139= 6.95, p= 0.01, Fig. 3a). Replicating our
ﬁndings in experiment 1, PPS reduced latency to initial
contact and decreased duration of each individual contact
during a social test, but administration of Relcovaptan
substantially reduced this effect (group*treatment: latency:
F1,64= 4.9, p= 0.004, contact: F1,64= 3.1, p= 0.03, data box-
cox transformed, Fig. 3b, c). For full statistical results please
see Supplementary Table 2a, and for means and standard
errors Supplementary Table 2b. There was no correlation
between AVP and any behavioural measure in the social task
(see Supplementary Table 2a for full statistical results).
Experiment 3
We next investigated AVP levels and social cognition
(assessed using the EKMAN 60 faces task) in participants
with BPD, a condition strongly associated with early life
stress. There was no signiﬁcant difference in age or sex
between control and BPD groups (F1,36= 1.1, p= 0.3).
Participants with BPD scored higher on the HADS (S=
192, p < 0.001) and CTQ across all abuse domains (emo-
tional abuse: S= 181.5, p < 0.0001; physical abuse: S=
231, p < 0.0001; sexual abuse: S= 261, p < 0.0007; emo-
tional neglect: S= 196, p < 0.0001; physical neglect: S=
218, p < 0.0001). Overall, BPD participants were worse at
recognising emotion in the EKMAN task (F1,36= 7.26,
p= 0.01, Fig. 4a), replicating some previous ﬁndings but
contrasting others69–71. This was not speciﬁc to any
emotion, as demonstrated by the lack of group*emotion
interaction (F5,180= 0.83, p= 0.53). There was also a
signiﬁcant effect of emotion, overall participants were
better at recognising happiness, and worse at recognising
fear (F5,180= 17.23, p < 0.0001). Plasma levels of AVP
were higher in BPD compared to control participants
(F1,28= 5.66, p= 0.03, Fig. 4b), reﬂecting the higher per-
ipheral AVP levels seen in the rat PPS model. Measure-
ment of AVP has been suggested as problematic due to
rapid clearance from circulation, instability in plasma and
high platelet binding72. Therefore, we also measured plasma
levels of copeptin, the c-terminal segment of the AVP pre-
cursor peptide, which has been suggested a more stable,
surrogate marker of AVP release73. Copeptin was also ele-
vated in the BPD patients (F1,28= 4.36, p < 0.05, Fig. 4c).
Within the BPD group only there was a negative correlation
between plasma AVP and number of errors in recognising
threat-related emotions, such that higher AVP corresponded
with enhanced responsiveness to negative emotions (average
Fig. 2 AVP levels after PPS. Following PPS, levels of AVP were elevated in a plasma and b supraoptic nucleus but not c paraventricular nucleus.
d A representative immunohistochemistry image. *p < 0.05. Error bars represent 1 S.E.
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of fear and anger, rS=−0.87, p < 0.0001, Fig. 4d). Higher
levels of emotional neglect were correlated with an increased
ability to recognise anger (rS= 0.7, p < 0.001) within the
BPD group. There were no other correlations between AVP,
emotion recognition and scores on the CTQ (see Supple-
mentary Table 3 for full statistical report).
Fig. 3 Effects of Relcovaptan on social behaviour after PPS. a Following PPS plasma levels of AVP were again elevated. PPS animals were b faster
to initiate contact, this was reversed by administration of Relcovaptan, and c displayed shorter duration of contacts, which was again reversed by
Relcovaptan. *p < 0.05. Error bars represent 1 S.E.
Fig. 4 Social behaviour and AVP levels in BPD and controls. BPD participants were a worse at recognising emotion in the EKMAN task, b had
higher plasma levels of AVP and c copeptin, and d within the BPD group only, higher AVP correlated with enhanced detection of negative emotions
(fear and anger). *p < 0.05. Error bars represent 1 S.E.
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Discussion
PPS resulted in altered social behaviour and elevated
protein levels of AVP peripherally in plasma and centrally
in the SON in rats. Relcovaptan, an AVPR1a antagonist,
reversed behavioural changes induced by PPS. Similarly,
individuals with BPD, a population with a high incidence
of childhood adversity, had elevated plasma AVP and
altered performance on tests of social emotion recogni-
tion. Furthermore, AVP levels correlated with increased
sensitivity to negative emotional expressions in the BPD
group. This suggests the AVP system is at least one
mechanism through which early life stress can result in
social difﬁculties in adulthood.
In our animal model, PPS resulted in a sustained
increase in AVP levels both peripherally (blood plasma)
and centrally (SON). AVP is mainly synthesised in the
magnocellular neurons of the SON and PVN and parvo-
cellular neurons of the PVN74. Parvocellular neurons
project to the zona externa of the median eminence, and
AVP originating from these neurons is suggested to be
intimately involved in neuro-endocrine HPA axis function
at rest and following acute and chronic stress75,76. In
contrast, magnocellular neurons project through the zona
interna of the median eminence to the posterior pituitary,
where AVP is stored in axon terminals and upon stimu-
lation, secreted into systemic blood circulation. This
suggests that increased peripheral AVP in our PPS ani-
mals is a direct result of the observed upregulation in the
magnocellular neurons of the SON. Previously, early life
stress in the form of maternal separation increased AVP
expression in the PVN of adult mice, but levels in the
SON were unaffected57. It is unknown whether elevated
PVN AVP would produce similar peripheral increases
following early life stress as the previous maternal
separation study did not examine peripheral AVP levels.
The differential effect of maternal separation and later
juvenile stress on AVP in different nuclei of the hypo-
thalamus could result from differences in the stress pro-
tocol (short-term physical stress vs. maternal separation)
or the developmental time point (PND 25–27 vs. PND
1–10). This highlights the importance of timing—it is
likely that different structures and processes are vulner-
able to stressful perturbations at different time points
during development. The nature of the stress is also likely
to produce different effects in SON and PVN—in adult
rats exposure to cold and heat stress increases AVP
expression in the PVN, whereas SON AVP only responds
to cold stress77. Furthermore, differences in the AVP
system following early life stress may not be apparent until
the system is challenged in a speciﬁc manner. AVP was
increased in the SON and PVN of maternally separated
adult rats and the SON of female prairie voles subjected to
chronic social isolation only after experience of stressful
intrasexual social, but not non-social, tests78–80.
In contrast to AVP, we found no changes in OXT fol-
lowing PPS. OXT is also produced in the SON and PVN
and responds to certain early life stressors. In rodents,
prenatal stress reduces OXT in the PVN, whereas
maternal separation has no effect (although OXT receptor
binding is altered)13,56,81–83. In humans, lower levels of
OXT have been detected after severe childhood mal-
treatment in women, and after early life stress before the
age of 12 but not during adolescence in men84,85. Con-
versely, less severe forms of childhood physical abuse
result in increased OXT in adulthood86, again high-
lighting the likely importance of stressor nature and
timing for later outcomes.
During a social interaction test, rats exposed to PPS
displayed decreased latency to initial contact and
decreased duration of individual contact bouts, and
number and duration of positively valanced ultrasonic
vocalisations were also reduced. Previous work has found
that PPS decreases conspeciﬁc social interaction in adult
males interacting with both adults (rats)21,23 and juveniles
(mice)20 (but see ref. 87). In animals, AVP is important for
social behaviour: disruption of AVP neurons impairs
social memory speciﬁcally, and AVPR1a−/− and
AVPR1b−/− mice demonstrate aberrant social recogni-
tion88–90. AVP infusion into the olfactory bulb and lateral
septum facilitates social recognition memory in rats, and
along with AVPR1a, AVP modulates aggression through
several brain regions51,91–94. This raised the question of
whether increased AVP following PPS in our animal
model was directly responsible for altered social beha-
viour. We therefore investigated the ability of an AVPR1a
antagonist, Relcovaptan (SR49059), to rescue behaviour
following PPS. Social behaviour resulting from PPS was
partially restored by administration of Relcovaptan, sug-
gesting that AVP mediates some of the effects of PPS on
adulthood social behaviour, and that this is a reversible
phenomenon. Other neurobiological systems and recep-
tors may also mediate the effects of PPS on later social
behaviour. AVP can also exert effects through AVP
receptor 1b and the OXT receptor to inﬂuence social
behaviour, and future experiments should address the
contribution of these receptor subtypes to the social
phenotype observed following PPS. The involvement of
other hormones with a known role in social behaviour,
particularly those which are known to be responsive to
early life stress (e.g., monoamines, corticotrophin releas-
ing hormone and glucocorticoids)12 should similarly be
investigated.
We next investigated whether AVP levels are also ele-
vated in a psychiatric condition associated with high levels
of childhood adversity, namely BPD. As with our animal
model, we ﬁnd that AVP protein was elevated in the
plasma of BPD participants. Concordant with animal
research, AVP and AVPR1a are strongly implicated in
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human social behaviour. AVPR1a promoter polymorph-
isms (particularly in RS3 microsatellite repeats) are asso-
ciated with variation in prosocial behaviour, especially
empathy and altruism, and polymorphisms in AVPR1a
and AVPR1b have been shown to associate with social
dysfunction in autism spectrum disorder83,95–98. In the
present study, BPD participants demonstrated altered
social behaviour. Speciﬁcally, they displayed decreased
sensitivity to recognising facial expressions of emotion in
the Ekman task when compared to controls. This sup-
ports previous ﬁndings of impaired social cognition in
BPD10,36,40,69,71. We also ﬁnd that higher AVP is corre-
lated with higher sensitivity to detect fear and anger in
this group, suggesting a role for AVP in the recognition of
emotions directly related to threat perception in BPD.
Interestingly, BPD are a group already known to display
heightened attention to threat related social cues41. In
agreement with our ﬁndings, in healthy individuals, some
studies have found that intranasal administration of AVP
enhances threat perception and detection of anger99,100.
Others have found the opposite effect, with AVP admin-
istration decreasing recognition of negative emotions in
men101. The precise effects may be affected by the parti-
cular group under study: intranasal AVP decreases anger
detection in schizophrenic men, yet improves fear
recognition in schizophrenic women101. Based on our
current results it may be predicted that AVPR1a antag-
onism would further impair recognition of fear and anger
in the BPD group, but we cannot predict the con-
sequences for recognising other emotions. This would be
an interesting area for future research.
We found no sex differences in response to PPS across
any of our measures, with males and females being equally
affected. There are well-known sex-differences in the AVP
and OXT systems, for example the expression of AVP and
AVPR1a are typically higher in males, and the adminis-
tration of AVP and AVPR1a antagonists can produce
differing effects in males and females102. Previous
research in our laboratory has demonstrated striking sex
differences in response to our PPS paradigm, for example
males display impaired fear conditioning and altered
hippocampal neurogenesis, whereas females are unaf-
fected103. Conversely, PPS females show greater altera-
tions in the hypothalamic–pituitary–adrenal axis104. This
demonstrates that males and females display sex-based
vulnerabilities and resiliencies to the lasting effects of PPS
in certain domains, but are equally affected in others,
highlighting the need to consider males and females in
pre-clinical and clinical studies. In the social interaction
task we found sex differences in behaviour regardless of
treatment, with males spending more time in contact
(increased average duration of contact and total contact
time) and females vocalising more and performing more
crawl overs and run-aways (see Supplementary Table 1).
This translational study provides evidence from across
species for the importance of AVP in relation to early life
stress and social behaviour. Of particular interest is the
fact that despite the different stressor types administered
in the animal model and experienced by the BPD cohort,
both populations experienced increased AVP and altered
social behaviour. The exact contribution and con-
sequences of different stressor types to the precipitation
of behavioural and biological alterations later in life are
not fully understood, and should form the basis of future
research. Our results demonstrate that the AVP system
may be a useful target for ameliorating social difﬁculties in
conditions associated with high rates of childhood
trauma, such as BPD, and that peripheral AVP levels may
represent a valuable biomarker for stratiﬁcation of treat-
ment in such groups. As a high rate of childhood adversity
is found in other psychiatric populations, for example
depression and anxiety, these would be valuable cohorts
for future study. Future studies should also aim to mea-
sure broader domains of social function, to further align
social measures between human and animal studies.
Additional scales and self-reports of social interaction
would be informative in human populations, and the
response of PPS animals to aversive social situations such
as tests of social dominance and resident-intruder para-
digms would prove informative and enhance cross-species
translation.
In conclusion, we ﬁnd that experience of stressful events
early in life is likely to play a role in the development of
social abnormalities in adulthood, and alterations in the
AVP system are at least partially responsible for this
effect. AVPR1a is a promising target for intervention in
disorders with a social phenotype, especially those pro-
duced thorough stressful early life experiences.
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